Transfuzní přípravky a krevní deriváty ve světle nových evropských doporučení při život ohrožujícím krvácení
Title in English | Transfusion products and blood derivatives in light of new European guidelines for severe bleeding |
---|---|
Authors | |
Year of publication | 2024 |
Type | Article in Periodical |
Magazine / Source | Transfuze a hematologie dnes |
MU Faculty or unit | |
Citation | |
web | https://redakce.carecomm.cz/tahd/article/view/2343 |
Doi | http://dx.doi.org/10.48095/cctahd2024prolekare.cz18 |
Keywords | bleeding; guidelines; blood transfusion; blood coagulation factors |
Description | Major bleeding is one of the most serious emergencies in medicine. This situation requires a complex therapeutic approach, including standardised administering transfusion products and blood derivatives. In the Czech Republic and Slovakia, the document “Diagnosis and Treatment of Life-Threatening Bleeding in Adult Patients in Intensive and Perioperative Care. Czech-Slovak Interdisciplinary Guideline” from 2017 remains valid. In 2023, an update of both European guidelines, from which the mentioned interdisciplinary procedure predominantly derives, was published. This work aims to identify and present changes in the European guidelines for severe bleeding since 2017. A total of 4 texts are included. Their analysis was divided according to individual transfusion products and blood derivatives. This work not only presents the new European guidelines for treating severe bleeding, but also compares these with the Czech-Slovak guideline from 2017. |
Related projects: |